AI MARKET SCANNING

NovaBridge Biosciences

AVG HISTORICAL GAP +0.01%
MAX GAP RECORD -6.85%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $NBP
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE)
+0.54%
Apr 07, 2026 Earnings Release 2026-04-07 (AFTER CLOSE)
+5.65%
Dec 18, 2025 Earnings Release 2025-12-18 (BEFORE OPEN)
+1.94%
Aug 20, 2025 Earnings Release 2025-08-20 (AFTER CLOSE)
-3.10%
Apr 03, 2025 Earnings Release 2025-04-03 (AFTER CLOSE)
-6.85%
Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE)
+1.87%
Aug 28, 2024 Earnings Release 2024-08-28 (UNDETERMINED)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.3%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $NBP

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

NovaBridge Biosciences operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗